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INTRODUCTION
A REVIEW OF THE HISTORY OF BLOOD GROUPS
At the beginning of the twentieth century there
developed a problem which was at first unnoticed and
unencouraged, and originally of purely theoretical
interest.

'fhis the blood group problem, first demonstra-

ted its practical importance to the question ot blood
transf11sions and other phases of clinical. medicine,. lat.er
in the fields of legal,medicine,

genetic~,

eugenics,

physiology, immunology, and anthropology.
During the nineteenth century many men tried transfusing sheep and other domestic animal blood into
human beings, but with poor results.

The number of

l.atal1t1• ca•sed scientists to investigate this

problem.

The subsequent experiments showed many things

s11ch as: the erythrocytes ot animals ot d1rterent species
vary in morphology; that hemolysis or agglutination ot
the red blood cells oeeur it h11man blood 1s mixed with
animal blood; that animals could be iDIJllunized with blood
or ser11Dl or other animals.

These observations led to

the theory of species specificity or the blood. (60)
Prompted by this theory, Landsteiner in 1900
investigated the q11est1on or whether or not there were
speo1f ic blood differences in individuals of the
same speoies.

He noted in his experiments that mixing

the serum or one individual with the cells of another,
marked agglutination occurred in some cases, while
in others the blood cells were unaffected. (60}
On the basis of his results, he was able to divide
human beings into three distinct groups.

The fourth and

rarest group was discovered by von Deca.stello and Sturli
in 1902. (54)

Landsteiner postulated from his results that there
exist two specific iso-agglutinogens in the red blood
cells, and that there exists two specific isoagglutin1ns in the serum.

The agglutinogens could

appear together in a blood, or either one could appear
singly.

Furthermore, that these elements were reciprocal,

that the presence of an agglutinogen in the blood precluded the presence of the corresponding agglutinin, and
the absence of an agglutinogen implied the presence of
the corresponding agglutinin. (54)
After these blood group experiments were confirmed,
Jansky in 1907 made the first definite classification
of the four groups.
fication.

Moss in 1910 devised another classi-

Finally, the international nomenclature was

adopted by the Health

Com~1ittee

of the League of

Nations; it is universally accepted at the present time.

By use of the latter olassitication, escaping the
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confusion ot the others, many mistakes of blood
grouping and its consequences were avoided.
Levine and Katzin made a survey of the classifications in use in American hospitals.

Their data shows

an increase in the use ot the InternationRl Nomenclature.
The interest in the med1o legal applications will
even stimulate more general use of it because heredity
of the blood is presented more clearly this way. (51)
Very little attention was paid to all this work
on blood groups before the first World War.
quently, many transfusion reactions occurred.

ConseDuring

the war the necessity for large numbers of transfusions
brought the subject into its true light.

The use of

donors with compatible blood resulted in successful
transfusions for the most r1art.

Transfusion became,

then, the first real application of blood grouping. (54)
After Landsteiner's discovery a continuation of
his studies in man and other animals showed that there
is a marked individuality of the blood of higher
animals, for instance, in apes, monkeys, dogs, cats,
horses, pigs, rabbits, birds, etc.

The constitutional

nature of the blood groups in man and animals was
obvious, because ot the constancy of the groups.
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The

constitutional nature of the individual differences of
blood hns been emphasized by the discovery that the
substances which characterize the four groups are
present in practically every tissue of the body and
have even been found in soluble form in serum, saliva,
semen and urine.

Their nature is emphasized further

by the fact that they are determined solely by heredity
and are not influenced by environment. (60)
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THE UNCOMMON BLOOD GROUPS
While attempting to find further differences
in the blood, Landsteiner and Levine (18) showed that
there exists a number of individual differences of human
blood, and that it is possible that these are due to
variations in substances rather than proteins.
Biochemically, there are two theories in regard to
the explanation of the differences of human blood. (18)
1) The thought has been expressed that variations in

proteins are the basis for the differences exhibited by
individuals of a species.

To substantiate this view

are the enormous numbers of proteins resulting from the
)ossible combinations of amino-acid.a.

There has been

no experimental evidence for this hypothesis, however.
2) Different 1e the view suggested by some that it is

probeble that the blood Antigens contain specific non-protein substs.nces--possibly of a lipoid na.ture.

Land-

steiner (15) showed that alcoholic extracts of blood exhibited group specificity--this seems to substantiate the
idea that proteins are not responsible for individual
varieties shown by serological reactions.

It is conceiv-

P.ble, on the other hand, that a particular protein may
be a constant characteristic of a species.
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Antibodies, being a special type of protein,
cannot be considered

an~logous

to those forming the bafis

of species specificity, which is inherent to all sorts
of proteins, such as hemoglobin, albumin, globulin, etc.,
aside from a few apparent exceptions.
The Subgroups of A and AB
In 1911 von DYngern and Hirszfeld found that the
blood group A was not homogenous. (5)

They absorbed

the serum of a person of group B and the red cells of a
person of blood group A. and noted that the absorbed serum
was able to clump the red blood cells of the majority of

persons of group A, although it failed to clump the cells
of some.

This observation was confirmed and finally led

to a division of group A into two subgroups, A1 and A2
and of group AB into A1 B and A?J3.

The phenomena described can also be produced with
group 0 serum and is apparently caused by the existence
of two agglutinins, a and a 1 • The agglutinin,a,acts on
all A and AB bloods, the agglutinin, 8i' acting on only
the majority of A and AB bloods, mainly those of A and
1
A1B. Bbods not reacting with the absorbed group 0 or group

B sera belong to the subgroup A and A B.
2
2

Group 0 and

B sera usus,lly contain both agglutinins a and a • (60)

1
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_J.a.tun of the Subgroups:
Wiener (58) was the first to report a case of
1so-immunization to the A agglutinogen. This brings
1
forward the old question of the nature of the differences
between the subgroups.

It becomes a very difficult

problem to understand whether the difference is
quantitative rather than qualitative.
It is generally acknowledged that the serum contains
two qualitatively different aggl•tinins, namely, a and
a. • In regard to the cells, the reactions have been ex1
plained by assuming two quqlitatively different A and
1
A2.

Lattes and Cavazutte (29) consider the difference
between the subgroups merely quantitative; that is, to
be caused by varying a.mounts of the same agglutinogen.
Landsteiner and Witt (28) offered evidence in
their experiments that there are two agglutinins, a
and a 1 , and from this assumed the existence of agglutinogena A and A •
1
2
Landsteiner and Levine (19) offered further evidence for qualitative differences in the subgroups
with their experiments on atypical agglutinins.
{See page 20. )
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The agglutinins, a and a 1 , are related to the
11 cold agglutinins", described by Landsteiner e.nd Levine
in 1926. (28)

The latter agglutinins dPrive their name

from the fact that they differ from ordinEcry isoagglutinins, in that their effect, generally, is much
diminished by increased temperature; that is, they
are much more active at 20° C. then at body temperature.
The "cold " agglutinins described by these men were a
e.nd a

1

end Alb;

they may even react at body tempere.ture,

which may account for some

subgro~p

incompAtibilities.(5)

The "cold" agglutinins are generally of two types,
one non-snecific (e.utoc:gglutinins) and specific, the
letter being related to the atypical agglutinins. (60)
These, in turn, are generei.lly of two

types, one related

to subgrou0s of A and the other is non-specific.

These

anomalous iso-agglutinins in the serum does not in any
way interfere with the determination of the group of

cells, since the erythrocytes give typice.l reactions
with typing ser&. {60)
The a 2 agglutinin is really an agglutinin directed
specifically to blood group O; it acts on A 2 cells only
because they are heterozygous and contain the factor O.
This explanation ( 55) does not a.ffect the arguments for
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a qualitative difference between the agglutinogene A1
end A2 . ba.eed u:i)on reactions with a· and ~ agglutinins.
Differentiation of the Subgroups in the Newborn:
The majority of newborn children hRVe no detectable
iso-agglutinins 1n their blood. ( 15)

These usm,lly a.ppear

during the first year of life and the titer rises gradually, until a peak is reached during adolesence.

Later,

a slow decline takes place, which continues through
life.

Davideohn (5) thinks the agglutinogens are well

established at birth, while Wiener (6J) states that the
agglutinogens have not reached their full develo,1ment at
birth.

For this reason, determination of any of the

subgroups of A or AB is not reliable for the blood of
an infe.nt.
The Significance ot the Subgroups--The1r Role in
Transfusions:
Generally, when blood of the subgroups of A and AB
are transfused, no reaction of any sort oceurs.

In

certain rare individuals, however, the body recognizes
the distinction between the subgroups and finds the
blood of the heterologous subgroups as foreign.

In

such individuals, with preformed irregular 1so-ant1bodies,
transfusions of the subgroups may be followed by a mild
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or no reaction whetsoever.

There would be a production

of more potent immune iso-agglutinins, so tha_t subsequent transfusions of blood of an incompatible
subgroup may lead to a severe or fa.tel reaction. ( 58)
The chances that the subgroups will c2use reactions
are not very great for gwo reasons: 1) The greater majority of bloods of groups A and AB do not con te_in either
of the

irregul:.:~r

iso-r:;gglutinins a

or a ; 2) The
1
2
irregulHr 1so-R.gglut1n1ns, when present at all, are of
such low potency, being active only at low temperatures,
in contr1=1st to a .c<nd b e.gglut1n1ns, which are present

~t 3? 0 c.

(58, 64)

Two rules must be followed in order to ascribe
tr2nsfusion reactions to the subgroups.

These are:

1) It is necessa.ry to show the.t the donor patient belong to different subgroups; 2)The patients serum must
contain a 1 or a 2 agglutinins, rather than some other
1soan ti body, such as the Rh fa.ctor. ( 58)
It is know that when blood of an incompatible
blood grou) 1s transfused, a serious or even fatal
hemolytic reaction may result, expecially in patients
whose sera contains potent nPtural iso-agglutinins.
Transfusions of blood which is incompatible may,
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in excPpt1onal instances, give rise to only mild symptoms-or none at all.

In these patients the natural

iso-aggl~

inins are probably of very low titer. (58)
No pet1ent receiving incompatible blood ever derives
full benefit from the transfusion
~~u1ckly

becausQ the blood is

hemolyzed and eliminated. (69)

Just after such transfusions have taken place it is
noted that there may be a drop in the !so-agglutinin
titer, due to the absorption of the 1so-agglut1nins
by

the transfused incompatible cells.

This is generally

followed by a rise in titer, far exceeding the original
level--due to the production of immune !so-antibodies in
resoonse to the introduction of foreign body cells.

A

second transfusion of incompatible blood a.t the high
titer level would probably give rise to a severe or fatal
regction. (58)
Observations made on patients, unintentionally,
indicFte that the properties A and B are antigenic for
individuals whose blood lacks the corresponding agglutinin.
As for the antigenicity of the subgroups of A Rnd AB 1 ,
there has never been any systematic study on this
question as yet. {58)

Only one case (?3) has ever been

reported of iso-immuniza tion of a.n A individual to
1

(11)

A2 blood. If tbe theory is correct that the ca:oa.c i ty
to immunize against the subgroups is restri2ted entirely to those individuals with corr·e spondir,g preformed irregular iso-agglutinins, then these eases must
be re.rer than immunization r'galnst A1 blood.
As stated before, agglutinin a 9 is very rare and
i.-'

seems to be of a Jifferent nature

t~Rn

a , because
1

it clumps red cells of group 0 in addition to those
of A 2 and tte ~gglutin· tion is usually more pronounced.
The proportion of persons with a 1 agglutinin is
larger in the subgroup A2B than in the subgroup A?.(5)
One can see the risk involved in the old idec; that
cross-matching is not necessary in universal recipients.
Davidsohn (5) states that it should apply only to
persons of subgroup A B whose blood is free of a 2
1
ag@:lutinin and to persons of subgroup A2 b whose b1ood lacks
agglutinin a .
1

The danger of

tr~·nsfusion

reac t1ons by the sub-

groups is not limited to incompatibilities, but also
failures to recognize subgrou9 A2 • Typing serP of
low titers are usually recuonsible; that is, a weak
agglutinating serum which fails to clump the weak
red celJ s.

The serum may beh:=,ve
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e~«9ctly

like the serum

of group O, and the dangers of the use of such a donor
can easily be seen.
A

survey by Levine and Katzin

(.~2)

showed that

such a practice is still common--that donors selected
on the baEis of blood grouping alone,

ithout regard to

cross-matching, pa.rticule.rly in reference to universal
donors.

Cross-matching, however, may fail to show the

true A 2 nature of the donors subgroup because of the
low titer of iso-agglutinine in the blood of some
patients.
There is

d~i.nger

of a reection when a false uni-

versal donor {e.ctually group A 2 ) is used for a .Ja.tient
of subgroup A1B, on account of the possible, though very
rare, presence of the agglutinin a 2 in the serum of people
of subgroup A1 B. Tl-. ere is also a h8 z··rd in the use of
a true universal donor for a recipient of subgroup A1 B
with agglutinin a , the latter reacting with cells of
2

group 0 even more readily the.n with the cells of
group A 2 • An actual case of iso-immunization of an
A B ind1v1duel by transfusion using group 0 blood has
1

been reported by Wiener, Hyman, and Or.emland, and
Samwick. ( 66)
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There exists a danger of a reaction between rare
a2c'glutinin

[~

2 and cells of subgroup A2 and group 0,

when a true universRl donor or an A2 donor is mistaken
for a donor of group o, and 1s used for a recipient of
A1 with rBre agglutinin a,._. (5)
Ye can see that since so many patients of group A
~'

have been tr nsfused with blood from group A donors selected at random, that it indicates the antigenic activity
for tt.ese subgroups must be weak.

Just the fa.ct that

there is an 1ntragroup A reaction does not meen that
the subgroups are to blame. (58)
In Wiener's and Peter's (67) report of their
experience with over 3,000 trensfusions, the evidence
of even minor reactions among patients of group A, when
donors are chosen without regard to subgroups, was not
more frequent than among pRtients in group O end B. In
fact, cases of iso-irnmun1zat1on against subgroups of A
are probPbly rarer than with the property Rh.
have related such experiences.

Others

'.Veiner ( 58) concludes that

the majority of 1ntragroup reactions are due to some
blood factor other than the subgroups.

He suggests that

some rare constitutional anomaly may be required to produce immune a.1 and e_ iso-antibodies.
2
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Possibly A

agglutinogen is poorly developed or perhaps the serum
contains weak irregular a 1 and a iso-agglutinins
2
from the ,eginning.
In view of these findings, then, it is safe to
disregard the subgroups when selecting donors for
transfusions, except in those rare cases when agglutinins
a 1 or a 2 are found. In that case the blood of the
homologous group should be used. (67) These agglutinins
can be de tected by cross matching.
Recognition

.2! the Subgroups:

Since most of the reports in related literature
suggest that in the greatest number of cases the errors
are due to the use of typing sera with low titers of
iso-agglutinins, it follows that it is imperative that
high titered sera are used in testing !or the subgroups.
Davidsohn (5) outlines in a detail a method for
the recognition of the subgroups.

He uses a highly

specific rabbit immune serum, which is highly titered
and easily produced.

A proper dilution of this serum,

as determined by titration, makes it possible to
differentiate the

..
s~bgroups

within five to ten minutes.

Wiener (6?) suggests the folllwing method of
cross-matching, as it will anticipate most 1ntra group
hemolytic

re~ctione:
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1)

Two drops of the patient's serum separated

from the clot at refrigere.tor temperature, plus one

drop of donor's cells, suspended in a test tube.
2)

The secnnd tube contrins a similar mixture of

the patient's serum and the patient's cells.
These tubes are plRced in ice water for five
minute8, then centrifuged while cold.

The reactions

are reed grossly and microscoyioally.

If there is

no reaction the donor is compatible.
a. reaction, it is

prob::~bly

If both tubes show

an auto-agglutinin and the

donor may be used.
Heredity

.2f

~

Subgroups:

Landsteiner and Levine (17) made the first studies

on the heredity of the subgroups.

Later Friedenreich

lmd Worsaae proposed a theory of the heredity of the

subgroups.

The theory states that there exists four

allelomorphic genes

~'

A , B and R (absence of agglu2
tinogens) with genes A1 , A2 , and B dominant over R,

and A1 dominant over A2 . (60) It is suffice to say
here that instances of exceptions to this theory have
been reporte0. (17)

The

folllwi~g

rules should hold if this theory is

correct: (60)
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1)

The agglutinogen A1 cannot appear in the blood
of a child unless present in the blood of one or both
parents.

2)

This rule depends on the dominance of Ai over

An A1 B parent cannot have an A2 child and vice

versa.
3)

Children of subgroup Ar;f3 cannot result from

the matings A1 BxB and A1BxA B, unless the other parent
1
supplies gene A2 •

4)

In the matings A1xO,

A x~,

1

AixB, AfAiB, and

A1 xA 2B, if one child belongs to either group O or B,
none of the remaining children can belong to subgroup

A2 or A';f3 and conversely.
Studies on the heredity of the subgroups have
been scant.

The studies performed so tar, indicate

that the above theory is fundamentally correct.
Agglut1nogen ,!3 :
Wiener (60) reports that Fischer and Hahn, 1n 1975,
and Friedenreioh, in 1936, reported independently the
occurrence of persons of group A whose blood gave very
feeble reactions with the most potent anti A sera.
They attribute this reaction to the existenoe of a
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third subgroup A • This discovery gives rise to two
3
more subgroups--nGmely, A3 and A B. Friedenreich even
3
thinks there are additional subgroups of group A.
Further experiments show that these newer subgroups contain agglutinin b as in ordinary group A
sera, and in addition may cont.:,in

8?•

"cold agglutinin",

as om A 2 or A B sera. Studies show that the occur2
rence of property A3 and A3B is determined by heredity;
and as Friedenreich (60) points out, the gene A is
3
recessive to genes A and A2 , but dominant over gene R.
1
Its practical importance, as we can see, lies in
the fa.ct that because of its pro9erties, it might be

eRsily missed, leading to errors in the typing of blood.
Prood of' a fourth al lelomorl1hic gene,

4 , has recently been reported by Gammelgaard and Marcussen. Its
r1.

importence is similar to agglutinogen A3 • (?3}

The Subgroups of Group B

After many unsuccessful experiments by noted
scientists in attempt to demonstrate the existence of
subgroups of group B, Friedenreich has shown that the
human B agglutinogen shows seve:ral distinct serological

-18-

properties, (60) designated by him as B1 , B2 , and B .
3
It has since been found by him that B2 and B3 are also
present in the bloods of lower animals.
Investigations on this subject and on agglutinins
analogous to a 1 and a 2 have not as yet reached the
stage where practical application is possible.
The Agglutinogens M and N
Since Landsteiner, 1n 1900, made his important
discovery of blood groups, there have been many attempa
made to discover further differences in human blood, in
addition to group distinotion.

Observations on individu-

al differences of human blood, aside from the tour
blood groups, indicated that the bloods of individuals
is not identical biochemically, even though it belongs
to the same group. (l?,a)
Instances had been reported by Lindemann (40)
and others, in which the first transfusion with a
compatible donor was followed by severe symptoms.

There

were only casual remarks about the occurrence of atypical
iso-ant1bodies.
Landsteiner and Levine (17,a) reported the finding
of two cases in which they found atypical agglutinins.
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Landsteiner and Levine, in 192?, while working
on this problem, (17, 16) described the finding of
differences of human blood based on the use of immune
agglutinins.

They reported a sharp differentiation of

human bloods within the common blood groups, found by
absorbing a number of anti-human blood immune sera
from rabbits with blood corpuscles of certain individuals
regardless of group.

Two of the factors demonstrable by

these sera were designated as M and N.
These men found that three distinct types of human
blood could be distinguished, type M (the bloods
possessing M, but lacking N}, N (the bloods possessing N,
but lacking M), and MN (the bloods possessing both M
and N).

Not a single blood lacking both agglutinogens

was found.

It was also found that the distribution of

these types was the same in each of the four blood
groups, so that the agglutinogens M and N are unrelated
to the agglutinogens, A and B.

These differences point

to the fact that there is a high degree of biochemical
differentiation among individuals.
Fr1edenreich in 1936 (60) reported the existence
of oertain rare 1nd1v1duals of type MN whose blood

reacts we$kly with anti-N fluids.
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This factor was

designated by him as N2 • Blood containing N alone
2
has not as yet been reported.
Hered1 ty ..2...f ..!. and N:
The first report on the heredity of the agglutinogens
M and N was made by Landsteiner and Levine in 1928. (20)
These authors succeeded in demonstrating that M and N
are inherited as mendelian dominants and that their
heredity depends upon a single pair of allelomorphic
genes, M and N. (17a)
According to this theory, only three genotypes
are possible, MM, MN, and NN.
then, two

ru~es

According to this theory,

should hold as true: l} Agglut1nogen M

cannot appear in the blood of a child unless present
in the blood of one or both parents.
also hold for agglutinogen N.

This rule should

2) A type M parent cannot

give rise to a type N child--a type N parent cannot give
rise to a type M child. (60}

Exceptions to these rules

have been reported, however. (61,62)
Additional data shows that there is a higher incidence of the factor M among colored than white individuals.
(47) It has also been found that the distribution of
the two types is independent of sex, since the
frequency in both sexes is the same.
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These types have

been shown not to be sex-linked.

Landsteiner and

Levine (17) have shown that the distribution of the
factors M and N is not different in the four blood
groups, so that no correlation exists between these
two sets.

In addition, Wiener (63) confirms the re-

port of these two men, that agglutinogens Mand N
are probably inherited independently of agglutinogens
A e.nd B.

Development of

~

and

!:

Moureau (60), according to Wiener, has been able to
demonstrate the presence of the agglutinogens M and N in
human fetuses as early as the second month of intrauterine life.

It has also been definitely shown that

these agglutinogens can definitely be demonstrated at birth.
However, no thorough studies on this subject hAve, as yet,
appeared in the llterature.
Other Differences ot Human Blood
Demonstrable by Anµial Sera
Agglutinogen

f:

At the time Landsteiner and Levine (16) described
the M end N agglutinogens, they briefly described
another property also demonstrable by immune rabbit
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serum e.nd obtained, with some d1ff1cul ty. this
property which they called P.

Such immune sera were

found to give reactions similar to those of certain
extre.-agglutinins in human sera and of certain animal
ser~'.

From this

it was concluded (':,;) that the

properity P represented a group of related agglutinogens
and was not a single entity.
With regard to the relationship of agglutinogen P
to transfusions, Wiener (67) knows of only one case
where the injection of blood containing agglutinogen P
v.·as giv,-n to an individual lacking the agglutinogen

resulting in stimulating the formation of P isoantibodies.

The patient accordingly could use only

blood of the correct group P.
As for the heredity of the agglutinogen P,
Landsteiner and Levine (23) have shown that this factor
we.s

inherited.

Zieve, Wiener, and Fries (72) have

shown that this factor is not sex-linked or linked with
agglutinogens A-B, M-N in its heredity.

Dahr (60)

investigated this problem and found that P is inherited
as a simple mendelian dominant.

Agglutinogen Q:
Wiener states that two Japanese, Furuhata and
Imamura, have described an agglutinogen,Q, which tpey
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detected with an absorbed normal pig serum.

•his

property seems to be a correlation between the
renctions for P and Q., and is different from any of
the agglutinogens, A, B, M, and N.
Wiener, in his own work, found that agglutinogen

:,1

was similar to agglutinogen P, (60) in that it was
found much more frequently in negro than in white blood,
/'(nd the.t strong reactions f9r Q. gave strong reections
for P and weak reactions for Q ga.ve wea.k reActions for P.
He concluded that agglutinogen

~

belonged to the group

of agglutinogens designPted Rs P by Landsteiner and
Levine. ( 16)
Additional Differences:
Weiner (60) states that Andresen

desc1~1bed

a new

agglut1nable property found with human (OM) immune
rabbit serum.

He found that 45% of human beings had

this agglutinogen.

Landsteiner, Stratton, and Chase (24) obtained
an immune rabbit serum from the injection of negro
P blood.

This serum, after at>sorpt1·:n, gave reactions

for a new agglut1nogen.

They found that is very

rare and that all the bloods giving positive reactions
belonged to types N or MN.
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Using normal sheep immune serum, Schiff ( 0)
1

described a new agglutinogen, H, which he found to
be inherited as a simple mendelian dominant.
Using normal eel serum, SugishitA (60) described those human bloods which are agglutinated by
higher dilutions of

e~l

serum as type E.

Those bloods

P.gglutin2ted with undiluted eel serum, he designated
as e.

Sugishita described these agglutinogens as

hereditary qualitles.
Differences of Human Blood Demonstrable
by Human Sera
As pointed out previously, a small percentage of
normal human sera, in addition to the common isoagglutinins, contains "anomalous" agglutinins that
produce reactions of a lesser degree.

Instances of

these agglutinins have been reported ever since the blood
groups were first described, but they were not studied
systematically.
Several times sera containing these anomalous
agglutinins were discovered bec:ouse they geve rise
to tra.nsfusion reactions.

Thus, Ottengerg and Johnson

(49) discovered a rather active anomalous agglutinin
when a.n attempt was made to discover the reason for a.n
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unexpected transfusion reaction.

This agglutinin was

found in an individual of group B and was found to be
active at 37°0.
Culbertson and Ratcliffe (4) reported an intragroup transfusion ree.ction which they explained by an
anomalous agglutinin--acting on

90~

of all blood groups.

This serum could be used to detect the presence or
absence of e particular agglutinogen in human blood.
This agglutinogen was found to be similar to the
agglutinogen X.
Landsteiner and Levine (?l) investigated the
problem of anomalous agglutinins and found that the
most frequent of these were related to the subgroups
of A and AB.

One other which they found was similar

to tbe extra-agglutinin, 1, whose reactions corresponded to immune anti-P sera.

Reactions of other sera

could not be classified.
Nigg (46), in studies on the extra-agglutinin, 1,
concluded. that it was inherited indepen<lently as a
mendelian dominant.

-26-

THE Rh FACTOR
It was only unt11 recent-y that dangers inherent in
blood transfusions have received proper emphasis.

Earlier

li tere.ture contRins many reports of reections as a result

of such things as errors in typing, failure to crossmatch or other poor techniques.

As methods did improve

and as the number of reactions dropµed, more transfusions
were given. (9)

The frequent use of transfusions offered

scientists an o ~port unity to study the

~:irobl em

of the

effect of immunization of humnn beings with the blood
of other human beings. (60)
Landsteiner and Levine (23) were among the first to
report a case in which immune iso-a.gglutinins were
formed following repe2ted transfusions.

RecEc':tly, how-

ever, reports have appeared in the literature discussing
intragroup reactions, even with the most careful technique.
Culbertson and Ratcliffe (4), in 1936, called
attention to two group D patients in their puerper1um with
atypical agglutinins in their

s~rum--no

significance was

attached to it. Also,in the same year, Zacho reported a
case of a woman with a premature separation of the

placenta. (34)

The transfusions glven resulted in an
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accident which he attributed to atypical agglutinins
active on the donors cells.

He found that this ag-

glutinin had the property of greater activity at
3? 0 c than at lower temperatures.
Neter (45) reported a case of an intragroup transfusion accident which revealed the presence of an abnormal iso-agglutinin.

He noted that this agglutinin

was only temporary in character and gave its strongest reaction at warm temperi=ttures.
Levine and Stetson (38),in 1939, reuorted a case
of a very severe transfusion accident occurring in a
woman who had jut=t delivered a stillborn fetus.
accident followed transfusions of apparently
blood.

This

com~atible

They found that the reactions were independent

of the M. N. or P blood factors, and that the agglutinin
found in the patient's serum was very temporary in
character.

Their explane.tion of ttie case was based

on the as·umption that the petient wa.s immunized by an
antigen from the dead fetus when 1t we,s still in utero.
'l'his antigen, it was assumed, ·;;as inherited by the
fetus from the father.
Still more similar cases were reported (8,32,34)
and the basic cause remained unexplaineble until after
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the experiments of Landsteiner and Wiener in 1940.
The evidence presented in these cases could not be
eX})la,inerl. by the subgroups of A or AB beceuse their
properties wer'"" such that they were "cold agglutinins 11 ,
that 1s

their strongest reaction was at lower tem-

perRtures, and they were not of a temporary nature.
Not only that, but the reactions were found to be
independent B.lso of M, N, and P blood factors.
Observations made with immune sera, and espeoially from the evidence provided by test::, v:ith occasionally occurring normal and post-transfusion sera containing irregular agglutinins, one may conclude that there
are still many individual properties of human blood
that are not demonstrable by ordinary technique.

There

have been many attempts made to discover other ag.i'lutinogens by the technique used by Landsteiner and Levine, for
finding M, N, and P--that is, by using immune sera prepared by immun'iz1ng rabbi ts against human blood. (16)
These results turned out so poorly that the experiments
were given up. (24)
Consequently, other ways of approaching the problem
were tried.

One way was by immunizing laboratory

animals with other animals blood--think1ng that ''1erhaps
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animal blood contained antigens related to agglutinogens
in huma.n blood.

One result that favored this idel'l was

the experiment by Wiener and Landsteiner, in 193?,
where they showed that ct:rtain anti-rhesus immune serP
contRined agglutinins specific for human agglutinogen M.
( 25)

Pursuing this idea, these two men, in 1940, found
an individual property of human blood , which they detected by using rabbit immune sera, produced with the
blood of the Macacus rhesus monkey, with selected
human bloods.

This factor, different than any of the

other known agglutinogens, was designated by them as
Rh.

( 26)

The Rh Factor and Its Relation to Transfusions
Evidence of clinical importance of the Rh f'actor
was first obtained by ,1ener and Peters {67), when they
came into possession of some blood from patients who
had just shown hemolytic reactions after receiving repeated transfusions of blood of the proper group.

They had

noted that the greatest majority of intra group reactions
ever recorded occurred with intra or oost-partum pRtients.
In one of their cases they explained the hemolytic
reaction in this way:

The patient having group 0
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(Rh negative} blood and an apparently weak anti Rh
hemolysin 1n his serum was transfused with Rh positive
blood of the same group.

Repeated transfusions served

to stimulate the production of anti-Rh antibodies of
higher titer.

Accordingly, a later transfusion of

Rh positive blood gave r1se to an acute hemolytic
reaction.
Some months later than this report, Levine and
Katzin (34) reported several cases from which data was
available.

In one case, a post-partum patient was trans-

fused with blood from her husband.

A reaction occurred,

which they found WB.s caused by atypical agglutinins in
the woman's serum acting on the cells of the husband.
This tended to support the hypothesis of Levine and
Stetson

(38)

that under certain conditions, the mother

may be immunized by the fetus or fetal parts of the
placenta.

They called particular attention to the

similarity of this agglutinin to the anti-Rh of
Landsteiner and Wiener. (26}
Levine, Katzin, and Burnham (35) then reported
several cases in which the 1:tgglutinine found exhibited
a specificity different from that of anti M, N, or P.
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These agglutinins were shown to run parallel to the
anti-Rh of Landsteiner and Wiener. (26)

Tests done by

these men confirmed the report of sensitivity of
of these agglutinins at 37°0.

Consequently, they were

called "warm agglutinins" to differentiate them from
other atypical ones.

They again called attention to the

hypothesis of Levine and Stetson (38) as a probable
explanation of the origin of these agglutinins.
Levine and Polayes (37) reported an intra-group
reaction in a patient in her puerperium.
been previously transfused.

She had never

They again used Levine and

Stetson's hypothesis (38) for an explanation of the
reaction.
Scott and Conant (52) reported an intra-group
reaction occurring after reoeated transfusions.

They

proved this reaction to be due to the formation of
anti-Rh agglutinins in the patient's serum, so that
subsequent transfusions gave rise to a reaction.
All of these cases and subsequent findings raise
the question of why these reactions a.re not encountered
more often.

Wiener and Peters (67) explain it by the theory

that not all Rh individuals are cap;:ible of producing Rh

antibodies.

Some special constitutional factor may be
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required, possibly the presence of preformed antibodies.
Also that the interval between the transfusions must be
long enough to permit an adequate rise in the titer of
the antibody.
It is probe.ble that the anti-Rh agglutinins are
responsible for about 90% of all intra-group transfusing,
accompanied by adverse results, or in pregnancy at the
first transfusion.

In short, it means that certain

Rh negative individuals can produce anti-Rh agglutinins
either by immunization with the Rh factor of the fetus
or by iso-immun1zat1on with Rh positive donors of the same
group.
That the property Rh is a true antigen is established
by its ability to produce immune antibodies.

(6?)

!so-antibodies for Rh do not occur normally in human
plasma, and the transfusion of blood containing Rh into
patients whose blood does not have iso-antibodies for
this agglutinogen, is uneventful ordinarily (58), the
transfused cells surviving in the patient's circulation
for periods un to three to four months. (68)
However, for the certain percentage of patients who
do not have the Rh f'a.ctor, only blood that is free from

Rh is suitablP for transfusion.
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In case Rh positive

blood is injected into patients whose blood is Rh
negative, the body recognizes it as foreign a.nd tries to
eliminRte it.

The first transfusion shows gradual hemo-

lysi::::, so that there are no visible symntoms.

This hemo-

lysis, however, is followed by the appearance of Rh
iso-antibodies and subsequent transfusions of Rh positive
blood may result in a fe.tal or severe reaction. ( 67)
The Rh Factor and Erythroblastosis Fetalis
Shortly after Levine and Stetson (38), in 1939,
stated their hypothesis of 1so-immunizat1on, Burnham,
Levine and Katzin (35) associated intra-group transfusion accidents with the etiology of erythroblastosis
fetalis.

Shortly after this, Landsteiner and Wiener (27)

in 1941 were the first to report that the agglutinogen
Rh WRs responsible for the severol manifestations of

this disease.
It is interesting to note here the countless
artic-es and the many theories that have been written
in connection with erythroblastosis

fet~lis.

The mani-

festations of this disease, icterus gravis neonatorum,
hydrops fetalis, and congenital anemia, were at first
considered different entities, until after much research
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had been accomplished, authors,genere.lly, began to find
similarities in the underlying 9athology (11, 42,6) of
these conditions.

Finally

Clifford and Hertig (3)

concluded that erythroblestosis fetalis is descriptive
of the seme underlying pathological process.
In earlier literature, most of the theories as to
the etiology of this di see se offered inadequate explcmat1ons as to the possible causes.
to the etiology

~as

The actual concept as

developed from the studies on

atypical agglutinins which have already been discussed.
It is of interest to note an article written by
Ottenberg in 1923 (47) on the etiology of eclamp2ia.
He expressed his belief the.t the etiology of eclampsia
lies in the fact that there is probably a. transfusion of
incompatible blood of the child into the mother's circulation, a.s a result of a. communication through the
placenta.

He also expresses the belief that several other

unexplained diseases euch as jaundice of the newborn and
certain cases of hemorrhagic disease of the newborn might
also be due to accidental placental transfusion of incompatible blood from the mother to the fetus.
Darrow in 1938 (8) concluded., after a long study,

thAt: 1) The primary influence giving rise to the
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pathological processes in a series of children with
erythroblastosis in the same family must be traced to
the mother; 2) An antigen-antibody reaction seems to
explain the best, all aspects of the related disorders
in this disease.
Levine, Katzin, Burnham (35), in 1941, discussed the
possible bee.ring of iso-immunizet1on in pregnancy to the
etiology of erythroblastosis fetalis.

They referred to

a series of seventeen patients in which atypical
agglutinins could be demonstrated.

They presented

sufficient evidence to show that these atypical
agglutinins ran parallel to the Rh factor of Landsteiner
and

~iener.

The patients presented histories of

various obstetrical complications, such as toxemia,
macerated fetuses, repeated Abortions, miscarriages,
and three of erythroblastosis.

They stated that it is

probable that there is a connection between the
occurrence of these complications and the presence of
immune-agglutinins in the mother.
This relationship suggested a theoretical

b~sis

for the etiology of erythroblastosis fetalis in some
c~ses

2nd the hypothesis of iso-immunization could

readily explain the familial incidence.
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They assumed, then, that the aty-;:,ical .s.gglutinins in the mothers serum were capable to going
through the plccental b['-rrier so that the e.ntibodies,
by their continual action on the red blooa cells

and

perhaps feta.l tissue cells, induced erythroblastosis fetal is.

In the presence of

9

sufficient amount of agglutin-

ins, the fetus may die in utero. (See Levine and Stetson,
Ref. 38)

Similar explanPtions may apply for some still-

births, miscarriages, a.nd abortions; in fact, Burnha."m
(1) even suggests that the erythroblastosis group be
broadened to include some of the macerated fetuses
not due to syph111s, diabetes, or toxemia, and many,
if not most, of the anemias of the newborn.
In later work, Levine, Katzin, and Burnham (39)
considered as true

the fact that erythrobli:stosis

fetalis results from the passage of the mother's immune
iso-agglutinins through the placenta to act on the susceptible blood of the child.

The immGne iso-.s.gglutinlns

resulting from immunize.tion of the Rh negative mother by
Rh positive blood of the fetus. (27)
According to the theory of iso-immunization, the
immune

~gglutinin

passes through the placenta and

ex~rts

a lytic action on the susceptible fetal blood.(39)
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This, however, could not occur if the Rh factor had a
wide distribution throughout the tissue cells and body
fluids

because it would then specifically bind the

anti-Rh agglutinins.

Recent tests (39) show no evi-

dence of the Rh factor in numerous samples of saliva,
seminal fluid, or sperm cells of an Rn positive
individual.

Tbis then seems to subEtant1ate the theory

that the Rh factor is limited to the red blood cells.
However, there should be a comprehensive study of various
body organs and fluids as Kosjakov and Tribulev (14)
did with the agglutinogen M and N.
In

erythrobL~

s tosiE, nothing is known of the

circumstances which permit immunization of an occBsional
Rh negative mother by an Rh positive baby and not the
immunization of a vest majority of mothers.

Nor can

occasional ceses be expla.ined in which the anti-Rh
agglutinin was formed in the mother but caused no
apparent harm in the be.by.

It ce.n be se.id that the

prevention of erythroblastosis fetalis is still un"-.nown.
If recognized in time, most be.b1es live long enough to
be cured by transfusions.

(1)

In a statistical study on the relationship of the
Rh factor to the pathogenesis of this disease, Levine
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Vogel, Katzin, and Burnham made the following observations:

(3Sl)

Of 111 mothers of infants with erythroblasto-

siE 9% were Rn positive and 90% were Rh negative. Sixtysix husbands of these mothers were

1007~

Rh positive,

and 58 affected babies were 100% Rh positive.

These

men assumed, then, that these findings explained the
incidence of erythroblnstosis in 91% of the families
studied.

Levine and Polayes (3?) have shown that there

are other blood factors inducing iso-immunizat1on.
There is considerable

evid~nce

at the present time

that the familial nRture of erythroblastos1s fetalis depends on the heredity of the blood factors involved.
The incidence in certain mothers and the sporadic occurrence in others, would seem to be due to the homo or
heterozygosi ty of the father's blood. ( 37)
It may be of interest to the rea.d;:;.r to refer to a
recent case of erythroblastosis fetalis occurring at
the University of

1~ebraska

Hospital. (?)

after living only two days.

The child died

Smears were taken of the

father's mother's and child's bloods by Dr. J.P.
Tollman.

These smears were to Dr. Wiener, who later

the following

information~

Father, group OM, Rh positive;

Mother, group OM, Rh negative; Child, group OM, Rh
positive.
-39-

The Rh Factor and Blood Dyscrasias
Observations by Wiener (60) supply an explanation
for conflicting clinical results obtained by different
clinicians in the treatment of blood dyscrasias or other
diseeses when repeated trf.lnsfusions are given.

She"rpe

and Davis (53) reported two cases of severe crises in
hemolytic jaundice in which repeated transfusions
cPused dangerous reactions.

They concluded from their

experience that transfusions are dangerous in the presence of severe crises, and are countra-indicated preoperative1 y (to spleenectomy).

Among other men warning

against the use of transfusions in hemolytic jaundice
were Wise (70) and Hartfall and Stewart (10).
The unsatisfactory results obtained by some investigators can probably be attributed to inapparent
hemolysis of the donots blood, or to

P

hemo 1 ytic reaction

due to the presence of iso-antibodies in the
serum, giving

reaction~

patien~s

independent of the blood groups.

( 58)

From a series of ten cases, Wiener (58) seems to
think that the majoritj of such iso-antibodies correspond to the property Rh.

The correct use of Rh blood
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in such cases will be more effective in preventing reactions and correcting the anemia.

This theory can also

be used to explain occasional severe he:nolytic reactions
in post-partum patients.
The Rh Factor and Group 0
The use of group 0 as universal donor was first
suggested by Ottenberg in 1911. (48)

He showed at

that time that incompatible agglutinogens in the donors
blood usually caused a hemolytic reaction, but that
atypical agglutinins caused little or no change.

He

explained this by the theory that probably the foreign
agglutinins were diluted upon entering the patient's blood,
and were not in sufficient concentration to cause a
reaction.
In 1923 Levine and Mabee (36) warned that indiscriminant use of group O as donorE should be avoided
because their titer of agg1ut1nins or hemolysins
might be .exceptionally high, and in that way may produce a hemolysis of the donor's blood.
Wiener (5S) showed that such reactions are not
lbrays

explained in this way.

He demonstrated , in

some cases, that in such transfusions hemolys1s of
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of the donors (Rh positive ) blood was due to the Rh
iso-Hntibodies in the patient's serum.

Consequently,

he suggested that a person of group 0. with Rh negative
blood and weak iso-agglutinins in his serum, would be
a

11

safe" universal donor except in those very rRre in-

stances where hemolysi- o curs in a patient of subgroup A1 B or A1 , when the rPcipients serum contains
natural or immunizational anti-0 iso-antibodies.
Heredity of the Rh Factor
Landsteiner and Wiener, in 1941 (27), studied the
heredity of the Rh factor in sixty families with '.?37
children.

In analogy to the other human blood proper-

ties, they presumed, by their studies, that Rh is transmitted by a pair of genes, Rh and rh, a
recessive.

domi~ant

and a

Examination of these families showed that

the agglutinogen was inherited as a simple mendelian
dominant which is not sex-lir:ked.

They also found that

the Rh factor has a higher incidence among negroes.
They suggested that further studies be m-::,de to
prove that the Rh factor is not linked to A, B, M, N,
or P in its heredity, as they surmised.

If this is true,

the property Rh may serve to mark a new pair of
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chromosomes for linkage studies.
Wiener and Peters (67) reported the frequency distribution of the agglutinogen Rh in the general population
as 85% Rh positive and 15%

Rh neg··tive.

RS

Determination of the Rh Factor
The term n._.. arm 11 agglutinin has been avplied to
the Rh agglutinins because it was observed that they react fe.r better at 3?°C, body temperature, than at
lower temperature.

In this respect they differ from

other atypical agglutinins.
Levine recommended

~30)

Because of this reason,

in cross-matching that the

patient's serum and donors cells be incubated for at
least 30 min~tes at 37°C, then centrifuged at a slow
speed (500 r.p.m.) for one minute.
Since there is not as yet an available source of
anti-Rh agglutinins obtainable for the selection of Rh
neg~tive

donors, this method is considered adeluate for

typing.

'Much ce.n be done to prevent intra-group reactions

in mothers with its forty to fifty per cent mortality.
It is believed thB.t almost all, if not all of these
rea.ctions can be prevented by this method.

Should the

mother of a possible erythroblastosis bi::by require a
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transfusion, it is much safer to find, first of all,
her Rh status ti.nd find a compatible donor. (9)
Landsteiner and Wiener ( ·:i7) have also suggested a
method for the determinatio1 of the presence or absence
or the Rh fA_ctor, which can be used for typing patients
and prospective blood donors

Tbis method is to absorb

the sera, diluted one to four, with a quantity of blood
(A or B cells if indicated) suffi~ient to remove the

reaction with Rh negative blood.

Then two drops of the

test fluid ere mixed with one dro_p of 2% (in terms of
blood sediment) washed blood suspersion, freshly prepared
in a narrow tube of ? mm. diameter and allowed to stand
e.t room temperature for thirty minutes to one hour.
Inspection of the bottom of the tube with a hand
lens shows negative reqcting bloods exhibiting a circular
deposit with a smooth edge, while positive reacting bloods
ha.ve sediment with a wrinkled or a serrated border or
else show a granular deposit.
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SUMMARY AND CONCLUSIONS

The uncommon antigens and their corresponding
agglutinins were discussed.

The uncommon antigens dis-

cussed were: 1) The subgroups of groups A and AB; 2) The
subgroups of group B; 3) Agglutinogens M, N, MN, P, Q.,

H, E, e,

Rh, and others which are, as yet, unnamed;

4) Extra agglutinin, 1.

In view of the discussion presented, it is safe to
disregard the subgroups of A and AB when selecting donors,
except in those rare CRses when agglutinins n1 or
found.

A0

are

In order to ascribe transfusion reactions to

the subgroups, it is necessary to show that the donor and
patient

belo~g

to different subgroups, and that the

1 or a 2 agglutinins. The
dangers of reaction by the subgroups is not limited to

patient's serum contains

&

incompatibilities, but also failures to recognize the
subgroups, A2 .

Methods of

cro~s-matching

which will detect the subgroups.

are given,

The subgroups are

inherited, according to Mendel's Laws, allelornorphic
genes, A1 , A2 , Band R, with genes A1 ,Ai;::i,P.nd B dominant over R, and A1 dominant over A •
2
The agglutinogens M, N, and Pare characterized
oy their lack of antigenicity.
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Not a single transfusion

reaction can be traced to types M and N despite the
hundreds of thousand.s of transfusions that have been
given.

However, among thousands of people tested, only

three he.ve been found with natural anti-M iso-agglutinins,
none hnve been found with anti N iso-agglutinins.
According to the theory of 12.ndsteiner And Levine
(20)

the properties M and N are inherited as mendelian

dominants.

Their heredity depends upon a single pair

of allelomorphic genes.
It is noted that agglutinogen M is found more
in negroes than in whites.
As for the agglutinogen P, only one case is known

where p antibodies have been formed in a human being
after injection of blood containing agglutinogen P.

It

is inherited as a mendelian dominant nnd is not sexlinked.
It can be said of the other properties discussed that
in general, the role played in transfusions is that they
show marked difference as to their significance.

As

yet, m"ost of them have not reached the stage whe"·e
practical

ap~>l ica ti on

is possible. (subgroups of group B)

In other instances, their pract:cal importance lies in
the fact that, because of their properties, they might
easily be missed, leading to errors in typing blood.
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All the cases reported in the literature of intragroup reactions fall into two cat0gories: 1) Patients
given repeated transfusions, the

e~rliAr

trRnsfusions

serving to immunize them against the Rh antigen, and
later transfusions giving rise to hemolytic reactions;
2) Patients having reacti0ns following one transfusion;
every instance of this group occurred. in i tra or post
partum patients, the

s~urce

of the antigen h ving been

the fetus in utero.
Other conclusions show that erythroblastosis fetali s
is the result of: 1) Isa-immunization of an Rh negi:1tive
mother by the Rh blood of the fetus,and 2)the subsequent
passage of the mother's agglutinin through the placenta
to act on the

susce~)tible

blood of the fetus.

The Rh factor has been ehonm to be inherited as a
mendelian dominant and has been found to occur in 85%
of the population.
Recently, iliener (58) reported that reactions given
1

by Rh sera demonstrates the existence of more than one
sort of agglutinogen Rh, somewhat like the varieties
of agglutinogen A.
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